Crossmark

Impact of TET2, SRSF2, ASXL1 and SETBP1 mutations on survival of patients with chronic myelomonocytic leukemia

Crossref DOI link: https://doi.org/10.1186/s40164-015-0009-y

Published Online: 2015-05-20

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cui, Yajuan

Tong, Hongyan

Du, Xin

Li, Bing

Gale, Robert Peter

Qin, Tiejun

Liu, Jinqin

Xu, Zefeng

Zhang, Yue

Huang, Gang

Jin, Jie

Fang, Liwei

Zhang, Hongli

Pan, Lijuan

Hu, Naibo

Qu, Shiqiang

Xiao, Zhijian
Funding

Funding for this research was provided by:

National Natural Science Funds (81470297)

National Natural Science Funds (81270585)

National Natural Science Funds (81370611)

National Key Technology R&D Program (2014BAI09B13)
License Information

License valid from 2015-05-20
More Information

Article History

Received: 7 May 2015

Accepted: 12 May 2015

First Online: 20 May 2015